Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
LAB
vs
S&P 500
LAB
S&P 500
Over the past 12 months, LAB has underperformed S&P 500, delivering a return of -43% compared to S&P 500's +16% growth.
Stocks Performance
LAB vs S&P 500
Performance Gap
LAB vs S&P 500
Performance By Year
LAB vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Standard BioTools Inc
Glance View
Standard BioTools makes laboratory instruments and consumables used by researchers who study cells, proteins, and genes. Its products help scientists measure many biological targets from very small samples, especially in academic labs, biotech companies, and pharmaceutical research centers. The company sells hardware, test kits, and related reagents that are used together in recurring experiments. The business makes money in two main ways: selling instruments up front and then selling the consumables and assays those instruments require over time. That mix matters because the installed machines create repeat demand for follow-on products. Standard BioTools sits in the life-science research supply chain, where customers buy specialized tools to generate data for discovery, disease research, and drug development. What makes the company different is its focus on high-content measurement platforms for small, precious samples. Instead of general lab equipment, it builds instruments designed to run specific biological tests with a high degree of precision and workflow control. That gives Standard BioTools a niche role as a specialist supplier to scientists who need detailed information from limited material.